Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Editor Profile: Rudi Beyaert.

1, Rudi Beyaert2,3

  • 1The FEBS Journal Editorial Office, Cambridge, UK.

The FEBS Journal
|July 19, 2022
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing MALT1-mediated CYLD cleavage induces intestinal dysbiosis and reduces EAE severity.

EMBO reports·2026
Same author

Irisin ameliorates obesity and insulin resistance via adipose tissue IL-33 and regulatory T cells.

Nature metabolism·2026
Same author

Development and validation of a flow cytometry-based ISG15 induction assay to monitor the type I interferon response.

Clinical immunology (Orlando, Fla.)·2025
Same author

CARD14 signaling in intestinal epithelial cells induces intestinal inflammation and intestinal transit delay.

EMBO molecular medicine·2025
Same author

CREB regulates Foxp3<sup>+</sup>ST-2<sup>+</sup> T<sub>REGS</sub> with enhanced IL-10 production.

Frontiers in immunology·2025
Same author

Multi-step pathway engineering in probiotic <i>Saccharomyces boulardii</i> for abscisic acid production in the gut.

Metabolic engineering communications·2025
Same journal

PDC1 deficiency results in 2-deoxyglucose sensitivity through inhibition of Pdc2 activity in yeast.

The FEBS journal·2026
Same journal

Epigenetic regulation of the hepcidin gene expression in hepatoma cells.

The FEBS journal·2026
Same journal

Loss of Ambp ameliorates steatosis progression by activating PPARα signaling in zebrafish.

The FEBS journal·2026
Same journal

Varying susceptibility of subpopulations along the epithelial-mesenchymal spectrum to undergo EMT.

The FEBS journal·2026
Same journal

ALOX15 links lipid metabolism to receptor trafficking in platelet activation.

The FEBS journal·2026
Same journal

A two-component ortholog of the Niemann-Pick C 1 protein is essential for normal growth and sterol trafficking and signaling in Tetrahymena thermophila.

The FEBS journal·2026
See all related articles

This interview highlights Professor Rudi Beyaert, an expert in molecular biology and inflammation research. He shares insights into his work and the future of molecular signal transduction in inflammation.

Area of Science:

  • Biomedical Molecular Biology
  • Inflammation Research
  • Molecular Signal Transduction

Background:

  • Professor Rudi Beyaert is a leading figure in Molecular Biology at Ghent University.
  • He directs the Unit of Molecular Signal Transduction in Inflammation at VIB Ghent.
  • Beyaert also holds a Vice-Science Director position at the Center for Inflammation Research.

Discussion:

  • This profile delves into Professor Beyaert's research interests and perspectives.
  • It explores his contributions to understanding molecular mechanisms in inflammation.
  • The interview touches upon his role in advancing the field of signal transduction.

Key Insights:

  • Professor Beyaert's work focuses on the molecular underpinnings of inflammatory processes.

Related Experiment Videos

  • His research utilizes advanced techniques in molecular biology to dissect signaling pathways.
  • He emphasizes the importance of interdisciplinary approaches in inflammation research.

    • Outlook:

    • Future directions in inflammation research are discussed, emphasizing novel therapeutic targets.
    • The role of molecular signal transduction in disease progression is a key area for future study.
    • Professor Beyaert anticipates significant advancements in personalized medicine for inflammatory conditions.